Centene Corp

CNC remains in a Stage 2 advance with rising EMAs and healthy structure, though a Bullish Exhaustion pattern signals waning upside momentum and potential pullback. Price is currently pulling back into the confluence of rising 9-EMA, 21-EMA, and 50-EMA on neutral RSI and Options Score, offering a favorable entry zone. Medium-term bias stays bullish absent a decisive breakdown, and short-term timing supports participation in the bounce now.

• ↑Q1 adjusted EPS $3.37 topped consensus; raised full-year guide to >$3.40
• ↑Medicaid HBR 93.1% and 4.5% composite rate increase drive margin gains
• ↓Earnings yield negative and weak profitability factors challenge margins